(Q57658557)

English

Évolution du traitement de sortie après hospitalisation pour syndrome coronaire aigu en France entre 1995 et 2000 : données des études Usik 1995, Prévenir 1 et 2 et Usic 2000

article

In more languages

Statements

scholarly article

0 references

Évolution du traitement de sortie après hospitalisation pour syndrome coronaire aigu en France entre 1995 et 2000 : données des études Usik 1995, Prévenir 1 et 2 et Usic 2000 (English)

0 references

hospitalization

1 reference

based on heuristic

inferred from title

author name string

N Danchin

1

0 references

G Hanania

2

0 references

O Grenier

3

0 references

L Vaur

4

0 references

E Amelineau

5

0 references

P Guéret

6

0 references

D Blanchard

7

0 references

J Ferrières

8

0 references

N Genès

9

0 references

J.-M Lablanche

10

0 references

C Cantet

11

0 references

J.-P Cambou

12

0 references

publication date

January 2003

0 references

number of pages

6

1 reference

based on heuristic

inferred from page(s)

Annales de Cardiologie et d'Angeiologie

0 references

52

0 references

1-6

0 references

1

0 references

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Management of acute myocardial infarction in intensive care units in 1995: a nationwide French survey of practice and early hospital results

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Epidemiology of myocardial infarction in France: Therapeutic and prognostic implications of heart failure during the acute phase

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Treatment of acute myocardial infarction by primary coronary angioplasty or intravenous thrombolysis in the "real world": one-year results from a nationwide French survey

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

[Efficacy of early reperfusion therapy at the acute stage of myocardial infarction in elderly patients: the USIK database]

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Caractéristiques initiales et prise en charge thérapeutique des sujets jeunes (âge inférieur à 45 ans) hospitalisés pour syndrome coronaire aigu : résultats des études françaises PRÉVENIR 1 et PRÉVENIR 2

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Optimizing the prescription of statins after an acute coronary syndrome: the influence of coronary angioplasty and total cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Use of secondary preventive drugs in patients with acute coronary syndromes treated medically or with coronary angioplasty: results from the nationwide French PREVENIR survey

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0003-3928%2802%2900181-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0003-3928(02)00181-6

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57658557&oldid=1984063779"